Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 7/7/2020
SIETES contiene 93061 citas

 
 
 1 a 20 de 30 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016;388:761-75. [Ref.ID 100609]
2. Cita con resumen
Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, Ceska R, Roth E, Koren MJ, Ballantyne CM, Monsalvo ML, Tsirtsonis K, Kim JB, Scott R, Wasserman SM, Slein EA, for the DESCARTES Investigators. A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med 2014;370:1809-19. [Ref.ID 97589]
4.Tiene citas relacionadas
Anónimo. Why do the results of randomised and observational studies differ?. BMJ 2011;343:1128. [Ref.ID 91915]
5.
The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000. [Ref.ID 87096]
6.Tiene citas relacionadas
McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S, for the INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-33. [Ref.ID 83625]
7.Tiene citas relacionadas
Lind L. Apolipoprotein B/A1 and risk of cardiovascular disease. Lancet 2008;372:185-6. [Ref.ID 83619]
8. Cita con resumen
Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet 2008;371:1547-9. [Ref.ID 82803]
9.Tiene citas relacionadas Cita con resumen
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. [Ref.ID 71323]
11. Cita con resumen
Singhal A, Cole TJ, Fewtrell M, Lucas A. Breastmilk feeding and lipoprotein profile in adolescents born preterm: follow-up of a prospective randomised study. Lancet 2004;363:1571-8. [Ref.ID 69993]
12. Cita con resumen
Anónimo. Pfizer's torcetrapib brings new approach to cholesterol. Scrip 2004;2942:23. [Ref.ID 69798]
13. Cita con resumen
Sniderman AD, Furberg CD, Keech A, Roeters van Lennep J E, Frohlich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003;361:777-80. [Ref.ID 65212]
14.Tiene citas relacionadas Cita con resumen
Wald NJ, Law M, Haddow JE, Craig WY. Apolipoproteins and prediction of fatal myocardial infarction. Lancet 2002;359:1864. [Ref.ID 62195]
15.Tiene citas relacionadas Cita con resumen
Walldius G, Jungner I, Aastveit A, Holme I. Apolipoproteins and prediction of fatal myocardial infarction. Authors' reply. Lancet 2002;359:1863-4. [Ref.ID 62194]
16.Tiene citas relacionadas Cita con resumen
Wägner AM, Ordóñez-Llanos J. Apolipoproteins and prediction of fatal myocardial infarction. Lancet 2002;359:1863. [Ref.ID 62193]
17. Cita con resumen
van Dam MJ, de Groot E, Clee SM, Hovingh GK, Roelants R, Brooks-Wilson A, Zwinderman AH, Smit AJ, Smelt AHM, Groen AK, Hayden MR, Kastelein JJP. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 2002;359:37-41. [Ref.ID 60856]
18.Tiene citas relacionadas Cita con resumen
Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-33. [Ref.ID 60071]
19.Tiene citas relacionadas Cita con resumen
Srinivasan SR, Berenson GS. Apolipoproteins B and A-I as predictors of risk of coronary artery disease. Lancet 2001;358:2012-3. [Ref.ID 60066]
20.Tiene citas relacionadas Cita con resumen
Hoffman AR. Should we treat the andropause?. Am J Med 2001;111:322-3. [Ref.ID 59503]
Seleccionar todas
 
 1 a 20 de 30 siguiente >>